The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Associations of PD-1 and PD-L1 Expression, MMR Status, and Prognosis in Esophageal and Gastric Cancer

Maria Svensson, MD
Published Online:9:45 PM, Thu February 1, 2018

Maria Svensson, MD, Lund University, discusses associations of PD-1 and PD-L1 expression with mismatch repair status and prognosis in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.